| アブストラクト | The Human Papillomavirus (HPV) Prevention and Control Board convened a meeting in Bucharest, Romania (May 2018), to discuss the role of healthcare providers (HCPs) in prevention programs, with a focus on HPV vaccination and cervical cancer screening. International and local experts discussed the role that HCPs can play to increase the uptake of HPV vaccine and screening. Experts recommended: 1) increasing HCP norms of getting vaccinated; 2) training providers to make effective recommendations; 3) making culturally appropriate materials available, in local languages; and 4) centralizing and coordinating education and information material, to direct both HCPs and the general public to the best material available. |
|---|
| 投稿者 | Vorsters, Alex; Bonanni, Paolo; Maltezou, Helena C; Yarwood, Joanne; Brewer, Noel T; Bosch, F Xavier; Hanley, Sharon; Cameron, Ross; Franco, Eduardo L; Arbyn, Marc; Munoz, Nubia; Kojouharova, Mira; Pattyn, Jade; Baay, Marc; Karafillakis, Emilie; Van Damme, Pierre |
|---|
| 組織名 | Centre for the Evaluation of Vaccination, University of Antwerp, Belgium.;Electronic address: alex.vorsters@uantwerpen.be.;University of Florence, Health Sciences, Florence, Italy.;Department for Interventions in Healthcare Facilities, Hellenic Center for;Disease Control and Prevention, Athens, Greece.;Immunisation and Countermeasures Division, National Infection Service, Public;Health England, London, UK.;Department of Health Behavior, Gillings School of Global Public Health,;University of North Carolina, Chapel Hill, NC, United States.;Cancer Epidemiology Research Program, IDIBELL, Catalan Institute of Oncology,;L'Hospitalet De Llobregat, Barcelona, Spain.;Department of Obstetrics and Gynecology, Hokkaido University Graduate School of;Medicine, Sapporo, Japan.;NHS National Health Services Scotland, Health Protection Scotland, Glasgow, UK.;Department of Oncology, McGill University, Montreal, Canada.;Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels,;Belgium.;Emeritus Professor at the Cancer Institute of Colombia, Colombia.;National Centre of Infectious and Parasitic Diseases, Sofia, Bulgaria.;P95, Epidemiology and Pharmacovigilance, Leuven, Belgium.;Vaccine Confidence Project, London School of Hygiene & Tropical Medicine, London,;UK. |
|---|
